Early research (Phase 1)Study completedNCT00801697
What this trial is testing
Safety and Immune Response to Preventive HIV Immunization With Adenovirus Serotype 5 or 35 Vector
Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 192